Given that the immunosuppressive microenvironment impedes immunotherapy, we evaluated tumor-associated macrophages (TAMs) with different phenotypes: CD11b+F4/80+CD206+ (M2-like, immunosuppressive) and CD11b+F4/80+CD86+ (M1-like, pro-inflammatory). The gene discussed is CD86; the disease is neoplasm.